1282P Activity of Brigatinib Based on Genomic Alterations Detected on Ctdna at Baseline and at Progression in ALK Inhibitor-Naïve Advanced ALK+ NSCLC from the ALTA-1L Trial
Annals of Oncology(2024)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined